Mya Roberson

University of North Carolina at Chapel Hill

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (11)

Yara G Abdou

University of North Carolina at Chapel Hill

UNITED STATES

View details

Elle Lett

University of Pennsylvania

UNITED STATES

View details

Caroline Thompson

Associate Professor

University of North Carolina at Chapel Hill Gillings School of Global Public Health

UNITED STATES

View details

Sarah Van Alsten

University of North Carolina at Chapel Hill

UNITED STATES

View details

Jennifer Elston Lafata

UNITED STATES

View details

Didong Li

Assistant Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Jihye Park

GlaxoSmithKline (United States)

UNITED STATES

View details

Ingrid Lizarraga

Professor

The University of Iowa

UNITED STATES

View details

Erin Kent

Associate Professor

University of North Carolina at Chapel Hill

UNITED STATES

View details

Christabel Cheung

Associate Professor

University of Maryland

UNITED STATES

View details

Xiaohua Gao

University of North Carolina

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mya Roberson

Research Interests

Explore related searches

Contact this professor

Articles (20)

Applying a Novel Measure of Community-Level Healthcare Access to Assess Breast Cancer Care Timeliness

An intersectional analysis of behavioral financial hardship and healthcare utilization among lesbian, gay, bisexual, transgender, queer, plus cancer survivors

Importance of LGBTQ+-Inclusive Language When Developing and Selecting Patient-Reported Outcome Measures

Population-specific patterns in assessing molecular subtypes of young black females with triple-negative breast cancer

Disparities in OncotypeDx Testing and Subsequent Chemotherapy Receipt by Geography and Socioeconomic Status

A latent class assessment of healthcare access factors and disparities in breast cancer care timeliness

Racial discrimination and health-care system trust among American adults with and without cancer

Advancing Equity at the JAMA Network—Self-Reported Demographics of Editors and Editorial Board Members

Anti-racism bystander training: A critical need in medical schools

Differential response to neoadjuvant endocrine therapy for Black/African American and White women in NCDB

A Qualitative Study of the Impact of the COVID-19 Pandemic on Metastatic Breast Cancer Care

Characterizing Epidemiology and Burden of Disease in Alopecia Areata - Making It Count

Envisioning trans-inclusive and trans-specific cancer care

Introducing the JAMA Dermatology Editorial Fellowship

Receipt of Bilateral Mastectomy among Women with Hereditary Breast Cancer

Trends in surgical treatment of early-stage breast cancer reveal decreasing mastectomy use between 2003 and 2016 by age, race, and rurality

Let’s get critical: bringing Critical Race Theory into cancer research

The impact of age and nodal status on variations in oncotype DX testing and adjuvant treatment

Validity of breast cancer surgery treatment information in a state-based cancer registry

Bridging Endocrine Therapy for HR+/HER2- Resectable Breast Cancer: Is it Safe?

Collaborators (11)

Yara G Abdou

Elle Lett

Caroline Thompson

Sarah Van Alsten

Jennifer Elston Lafata

Didong Li

Jihye Park

Ingrid Lizarraga

Erin Kent

Christabel Cheung

Xiaohua Gao

Make your next move.